There are 717 resources available
Opening session
Presenter: Solange Peters, Enriqueta Felip, Takayuki Yoshino, Florian Lordick, Anthony T.C. Chan
Session: Opening session and Keynote address - Beyond immune checkpoint blockade: Emerging strategies
Resources:
Webcast
Beyond immune checkpoint blockade: Emerging strategies
Presenter: Tak Mak
Session: Opening session and Keynote address - Beyond immune checkpoint blockade: Emerging strategies
Resources:
Slides
Webcast
Expanding the horizon for the treatment of lung cancer with ADCs
Presenter: Keunchil Park
Session: Daiichi Sankyo - Expanding the horizon for the treatment of solid tumors with antibody drug conjugates (ADCs)
Resources:
Webcast
Introductory note
Presenter: Tira Tan
Session: Pfizer - Clinical Evidence to Real-World Experience: Bridging the Best of Both Worlds in the Management of ER+ HER2- mBC
Resources:
Webcast
Real-world evidence of palbociclib & treatment approach in Asian patients
Presenter: Shaheenah Dawood
Session: Pfizer - Clinical Evidence to Real-World Experience: Bridging the Best of Both Worlds in the Management of ER+ HER2- mBC
Resources:
Webcast
Q&A and closing
Presenter: Tira Tan
Session: Pfizer - Clinical Evidence to Real-World Experience: Bridging the Best of Both Worlds in the Management of ER+ HER2- mBC
Resources:
Webcast
Live Q&A
Presenter: Ka-On Lam
Session: Bristol Myers Squibb - The role of immuno-oncology in the evolving treatment landscapes of upper GI cancers
Resources:
Webcast
Live Q&A + summary and close
Presenter: Hyun Cheol Chung
Session: Daiichi Sankyo - Expanding the horizon for the treatment of solid tumors with antibody drug conjugates (ADCs)
Resources:
Webcast
How are technologically advanced ADCs expanding the horizon for the treatment of solid tumours?
Presenter: Tony S.K. Mok
Session: Daiichi Sankyo - Expanding the horizon for the treatment of solid tumors with antibody drug conjugates (ADCs)
Resources:
Webcast
Expanding the horizon for the treatment of breast cancer with ADCs
Presenter: Rebecca Dent
Session: Daiichi Sankyo - Expanding the horizon for the treatment of solid tumors with antibody drug conjugates (ADCs)
Resources:
Webcast